Ardmore Shipping Corporation
NYSE:ASCMarine Shipping
+$0.08 today
- Market cap
- $717.77M
- Beta
- -0.01
- P/E (TTM)
- 11.7
- EPS (TTM)
- $1.43
- Dividend yield
- 3.89%
Volume 0.99M
Average 0.63M
ASC Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Ardmore Shipping CorporationNYSE: ASC
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents broadly unchanged from a year ago
Cash & equivalents stood at $47.21M at the end of Q1 FY2026, down 0.5% from a year earlier and up 0.8% from the prior quarter. Over 3 fiscal years it compounded at -2.5% a year.
Context
- Cash & equivalents amounted to 6.0% of total assets at the end of Q1 FY2026, down 0.9 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -0.5% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 46.85M USD
- Year-over-year change
- -0.3%
- 4-year CAGR
- -4.1%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 46.85M | -0.3% |
| FY2024 | 2024-12-31 | 46.99M | +0.4% |
| FY2023 | 2023-12-31 | 46.81M | -7.4% |
| FY2022 | 2022-12-31 | 50.57M | -8.8% |
| FY2021 | 2021-12-31 | 55.45M | — |
Cash & Equivalents vs competitors
How ASC compares with its peers on the latest reported figures
- ASC's Mar 2026 cash & equivalents of $47.21M is the 7th highest of the 10 companies compared; the peer median is $92.66M.
- Its year-over-year change of -0.5% is the 7th highest of 10, against a peer median of +26.7%.
- Cash & equivalents amounts to 6.0% of total assets for ASC, versus a peer median of 9.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
CMDBCostamare Bulkers Holdings Ltd | Mar 2026 | $293.93M | +130.6% | +33.6% | 28.3% |
| Mar 2026 | $171.78M | +42.9% | +45.0% | 12.1% | |
SBCSBC Medical Group Holdings Incorporated | Mar 2026 | $167.31M | +26.7% | +46.8% | 43.1% |
| Mar 2026 | $155.06M | +75.5% | +89.9% | 21.5% | |
| Mar 2026 | $92.66M | +37.8% | +23.2% | 5.6% | |
| Mar 2026 | $59.54M | -6.9% | -7.1% | 6.3% | |
| Mar 2026 | $47.21M | -0.5% | -2.5% | 6.0% | |
| Feb 2026 | $34.57M | -48.4% | -28.3% | 9.5% | |
| Apr 2026 | $28.19M | +11.7% | -19.3% | 5.5% | |
| Mar 2026 | $24.5M | -9.2% | +397.6% | 2.9% | |
| Peer median (excluding ASC) | $92.66M | +26.7% | +33.6% | 9.5% | |
Competitors are the stored peer set for ASC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 55.45M | 50.57M | 46.81M | 46.99M | 46.85M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 20.3M | 79.84M | 56.23M | 60.87M | 47.54M |
| Inventory | 11.1M | 15.72M | 12.56M | 11.31M | 8.91M |
| Other Current Assets | 3.82M | 9.45M | 4.35M | 4.3M | 4.87M |
| Total Current Assets | 94.22M | 157.74M | 126.78M | 126.55M | 111.85M |
| Property, Plant & Equipment (Net) | 606.49M | 547.47M | 538.13M | 556.02M | 639.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 11.08M | 11.22M | 11.19M | 5.24M | 4.98M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 12.74M | 7.43M | 14.86M | 17M | 31.99M |
| Total Non-current Assets | 630.32M | 566.12M | 564.17M | 578.25M | 676.87M |
| Total Assets | 724.53M | 723.86M | 690.95M | 704.8M | 788.72M |
| Account Payables | 8.58M | 8.81M | 2.02M | 6.07M | 5.07M |
| Short-term Debt | 15.1M | 12.93M | 6.44M | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 2.07M | 1.22M | 347K | 482K | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 1.6M |
| Total Current Liabilities | 58.5M | 52.93M | 33.84M | 29.83M | 25.85M |
| Long-term Debt | 130M | 115.87M | 39.59M | 38.8M | 127M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 943K | 1.01M | 954K | 273K | 268K |
| Total Non-current Liabilities | 337.03M | 164.49M | 82.67M | 39.55M | 128.54M |
| Total Liabilities | 395.54M | 217.42M | 116.51M | 69.38M | 154.39M |
| Common Stock | 364K | 426K | 433K | 440K | 443K |
| Retained Earnings | (119.92M) | 15.14M | 81.39M | 164.91M | 188.8M |
| Accumulated OCI | 1.04M | 1.47M | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 329M | 506.44M | 574.44M | 635.42M | 634.34M |
| Total Debt | 372.55M | 184.62M | 93.99M | 44.24M | 128.87M |
| Net Debt | 317.1M | 134.05M | 47.18M | (2.75M) | 82.03M |
Ardmore Shipping Corporation
NYSE:ASC
Intrinsic Alpha fair value
Locked
Current Price
$17.57
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.